Evidence map›Paper›PMID 40445399›Full record

ArticleArchives of dermatological research2025

Higher incidence of dermatological immune-related adverse events in cancer patients treated with immune checkpoint inhibitors vs. other treatments: a TriNetX research network study.

Rahib K Islam, Ryan Chan, Andrew Gross, Hassan Malik, Humza Pirzadah, Ahmed Abdelmaksoud, Christopher Haas, Manal Fawzy, Eman Toraih, Shari R Lipner

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rahib K IslamLouisiana State University Health Sciences Center, New Orleans, LA, USA.
Ryan ChanNew York Medical College, Valhalla, NY, USA.
Andrew GrossTulane University School of Medicine, New Orleans, LA, 70112, USA.
Hassan MalikLouisiana State University Health Sciences Center, New Orleans, LA, USA.
Humza PirzadahLouisiana State University Health Sciences Center, New Orleans, LA, USA.
Ahmed AbdelmaksoudDepartment of Surgery, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Christopher HaasDepartment of Dermatology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Manal FawzyDepartment of Biochemistry, Faculty of Medicine, Northern Border University, Arar, 1321, Saudi Arabia.
Eman ToraihDepartment of Surgery, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Shari R LipnerDepartment of Dermatology, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA. shl9032@med.cornell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer treatmentDermatological adverse eventsImmune checkpoint inhibitorsImmune-related adverse events (irAEs)Oncology dermatologyRashStevens-johnson syndromeVitiligo

Identifiers

PMID40445399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.